Editorial to Chuang et al

por Mantovani, Lorenzo G.
Publicado 2022

Perspectives to mitigate payer uncertainty in health technology assessment of novel oncology drugs

por Solà-Morales, Oriol, Volmer, Timm, Mantovani, Lorenzo
Publicado 2019

Correction to: Treat all COVID 19‑positive patients, but do not forget those negative with chronic diseases

por Viganò, Mauro, Mantovani, Lorenzo, Cozzolino, Paolo, Harari, Sergio
Publicado 2020

Distribution of Malocclusion Traits in the Pediatric Population of Milan: An Observational Study

por Caccianiga, Paolo, Mantovani, Lorenzo Giovanni, Baldoni, Marco, Caccianiga, Gianluigi
Publicado 2022

The economic impact of hypercholesterolemia and mixed dyslipidemia: A systematic review of cost of illness studies

por Ferrara, Pietro, Di Laura, Danilo, Cortesi, Paolo A., Mantovani, Lorenzo G.
Publicado 2021

Letter to the editor: Clinical Use, Quality of Life and Cost-Effectiveness of Spinal Cord Stimulation Used to Treat Patients with Failed Back Surgery Syndrome

por Scalone, Luciana, Mantovani, Lorenzo Giovanni, Lavano, Angelo, Costantini, Amedeo, Fortini, Gianpaolo, Zucco, Furio
Publicado 2017

Time-Varying Effect of Hybrid Immunity on the Risk of Breakthrough Infection after Booster Dose of mRNA COVID-19 Vaccine: The MOSAICO Study

por Ferrara, Pietro, Ponticelli, Domenico, Magliuolo, Roberto, Borrelli, Mario, Schiavone, Beniamino, Mantovani, Lorenzo Giovanni
Publicado 2022

Prevention of pneumococcal diseases in the post-seven valent vaccine era: A European perspective

por Weil-Olivier, Catherine, van der Linden, Mark, de Schutter, Iris, Dagan, Ron, Mantovani, Lorenzo
Publicado 2012

The use of individual patient-level data (IPD) to quantify the impact of pretreatment predictors of response to treatment in chronic hepatitis B patients

por Ali, Shehzad, Mealing, Stuart, Hawkins, Neil, Lescrauwaet, Benedicte, Bjork, Stefan, Mantovani, Lorenzo, Lampertico, Pietro
Publicado 2013

KRAS Early Testing: Consensus Initiative and Cost-Effectiveness Evaluation for Metastatic Colorectal Patients in an Italian Setting

por Barone, Carlo, Pinto, Carmine, Normanno, Nicola, Capussotti, Lorenzo, Cognetti, Francesco, Falcone, Alfredo, Mantovani, Lorenzo
Publicado 2014

SARS-CoV-2 pandemic: An overview

por Acuti Martellucci, Cecilia, Flacco, Maria Elena, Cappadona, Rosaria, Bravi, Francesca, Mantovani, Lorenzo, Manzoli, Lamberto
Publicado 2020

Cost-Effectiveness Analysis of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in Patients with Coronary and Peripheral Artery Diseases in Italy

por Ferrara, Pietro, Cortesi, Paolo A., Di Laura, Danilo, Maggioni, Aldo P., Mantovani, Lorenzo G.
Publicado 2021

Sedation strategies for pulsed-field ablation of atrial fibrillation: focus on deep sedation with intravenous ketamine in spontaneous respiration

por Iacopino, Saverio, Colella, Jacopo, Dini, Daniele, Mantovani, Lorenzo, Sorrenti, Paolo Francesco, Malacrida, Maurizio, Filannino, Pasquale
Publicado 2023

The Clinical and Economic Impact of Exacerbations of Chronic Obstructive Pulmonary Disease: A Cohort of Hospitalized Patients

por Blasi, Francesco, Cesana, Giancarlo, Conti, Sara, Chiodini, Virginio, Aliberti, Stefano, Fornari, Carla, Mantovani, Lorenzo Giovanni
Publicado 2014

Cost-effectiveness and budget impact analysis of siponimod in the treatment of secondary progressive multiple sclerosis in Italy

por Cortesi, Paolo Angelo, Antonazzo, Ippazio Cosimo, Gasperini, Claudio, Nica, Mihaela, Ritrovato, Daniela, Mantovani, Lorenzo Giovanni
Publicado 2022

XALIA: rationale and design of a non-interventional study of rivaroxaban compared with standard therapy for initial and long-term anticoagulation in deep vein thrombosis

por Ageno, Walter, Mantovani, Lorenzo G, Haas, Sylvia, Kreutz, Reinhold, Haupt, Verena, Schneider, Jonas, Turpie, Alexander GG
Publicado 2014

COSIMO – patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study

por Cohen, Alexander T., Maraveyas, Anthony, Beyer-Westendorf, Jan, Lee, Agnes Y. Y., Mantovani, Lorenzo G., Bach, Miriam
Publicado 2018

Indirect Treatment Comparison of Damoctocog Alfa Pegol versus Turoctocog Alfa Pegol as Prophylactic Treatment in Patients with Hemophilia A

por Vashi, Parth, Batt, Katharine, Klamroth, Robert, Mancuso, Maria Elisa, Majewska, Renata, Tiede, Andreas, Mantovani, Lorenzo Giovanni
Publicado 2021

The Value of Tucatinib in Metastatic HER2-Positive Breast Cancer Patients: An Italian Cost-Effectiveness Analysis

por Antonazzo, Ippazio Cosimo, Cortesi, Paolo Angelo, Miceli Sopo, Gerardo, Mazzaglia, Giampiero, Conte, Pierfranco, Mantovani, Lorenzo Giovanni
Publicado 2023

Rationale and design of XAMOS: noninterventional study of rivaroxaban for prophylaxis of venous thromboembolism after major hip and knee surgery

por Turpie, Alexander GG, Schmidt, André C, Kreutz, Reinhold, Lassen, Michael R, Jamal, Waheed, Mantovani, Lorenzo, Haas, Sylvia
Publicado 2012